BeStock  
Markets › Compare › AVT vs CYTK

AVT vs CYTK

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
AVT · Avnet$106.19 ▼ 0.70%
CYTK · Cytokinetics$62.70 ▼ 4.42%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

79114150185220Oct 7, '25Apr 7, '26Oct 5, '26
  • AVT +111.1%
  • CYTK +4.2%

Head to head

MetricAVTCYTK
Price$106.19$62.70
Change today▼ 0.70%▼ 4.42%
Market cap$8.72B$8.72B
Return, 3 months+30.9%-26.7%
Return, year to date+123.8%-1.3%
Return, 1 year+106.9%+3.4%
P/E (TTM)26.5-8.7
P/B1.7-50.2
P/E percentile vs own 5y––
Dividend yield1.32%–
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price––
Analyst buy share––
RSI (14)6727
30-day volatility41.6%36.1%
Max drawdown, 1 year-16.4%-28.1%
Trend readStrong uptrendStrong downtrend
Analyst consensus––

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • CYTK is the largest of the group by market value.
  • AVT has returned the most over the past year.
  • CYTK carries the lowest trailing P/E.
  • CYTK has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top